AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Accelerant Holdings

$19.84 +$4.23 (+27.10%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$19.84
Day Range
$19.84$19.86
Year Range
$9.18$19.9
Market Cap
4.33B
AVG Volume
3.05M
Trailing/Forward PE
-2.98/21.28
PEG ratio
-0.69
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
0250M500M750M1B20242025
ARX Revenue (USD) by year
PeriodRevenue (USD)
2025865M
2024579.64M
Net Income (USD)
-1.5B-1B-500M0500M20242025
ARX Net Income (USD) by year
PeriodNet Income (USD)
2025-1.35B
202427.2M
Operating Income (USD)
-1.5B-1B-500M0500M20242025
ARX Operating Income (USD) by year
PeriodOperating Income (USD)
2025-1.32B
202432.24M
EBITDA (USD)
-1.5B-1B-500M0500M20242025
ARX EBITDA (USD) by year
PeriodEBITDA (USD)
2025-1.23B
202472.94M
Cash Flows (USD)
0200M400M600M800M20242025
ARX Cash Flows (USD) by year
PeriodCash Flows (USD)
2025433.5M
2024751.1M
EPS (USD)
-8-6-4-20220242025
ARX EPS (USD) by year
PeriodEPS (USD)
2025-6.92
20240.13
Expenses (USD)
0200M400M600MSG&ACapex20242025
ARX Expenses (USD) by year
PeriodExpenses (USD)
2025436.7M
2024280.8M
Cash & Debt (USD)
01B2B3BCashLong Term DebtShort Term Debt20242025
ARX Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20252.51B
20241.29B
Debt ratios
012320242025
ARX Debt ratios by year
PeriodDebt ratios
20250.25
20242.26
Margins
0%20%40%60%80%20242025
ARX Margins by year
PeriodMargins
202567.13%
202457.09%
Return on Capital
-200%-150%-100%-50%0%50%20242025
ARX Return on Capital by year
PeriodReturn on Capital
2025-186.41%
20246.37%
Shares Outstanding
0100M200M300M20242025
ARX Shares Outstanding by year
PeriodShares Outstanding
2025221.82M
2024162.5M
Book Value Per Share (USD)
0123420242025
ARX Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20253.27
20242.63
Total Assets (USD)
02.5B5B7.5B10B20242025
ARX Total Assets (USD) by year
PeriodTotal Assets (USD)
20258.26B
20246.09B
Employee Count
01002003002025
ARX Employee Count by year
PeriodEmployee Count
2025250
PE Ratio
50100150200med 83.06Jul 25Aug 25Sep 25Sep 25Oct 25Nov 25
ARX PE Ratio by year
PeriodPE Ratio
Nov 2562.63
Oct 2557.57
Oct 2561.78
Oct 2564.01
Oct 2569.37
Oct 2573.82
Sep 2573.43
Sep 2580.86
Sep 2585.27
Sep 2599.84
Aug 2599.34
Aug 25183.58
Aug 25173.07
Aug 25168.18
Aug 25164.09
Jul 25181.99
Free Cash Flow Yield
0%10%20%30%40%med 15.79%Aug 25Oct 25Jan 26Mar 26May 26Jul 26Sep 26
ARX Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 261.18%
Sep 261.18%
Aug 261.19%
Aug 261.19%
Aug 261.19%
Aug 2611.58%
Jul 2612.14%
Jul 2610.14%
Jul 2610.67%
Jul 2611.41%
Jul 2610.48%
Jun 2610.5%
Jun 2611.1%
Jun 2611.07%
Jun 269.62%
May 269.04%
May 268.36%
May 269.34%
May 2614.81%
May 2614.93%
Apr 2614.88%
Apr 2613.87%
Apr 2615.3%
Apr 2614.57%
Mar 2615.02%
Mar 2615.09%
Mar 2627.9%
Mar 2626.58%
Feb 2625.32%
Feb 2629.12%
Feb 2628%
Feb 2625.49%
Jan 2621.87%
Jan 2620.12%
Jan 2619.87%
Jan 2618.91%
Jan 2619.14%
Dec 2518.1%
Dec 2518.32%
Dec 2519.07%
Dec 2519.61%
Nov 2520.51%
Nov 2523.05%
Nov 2522.03%
Nov 2528.4%
Oct 2530.89%
Oct 2528.79%
Oct 2527.78%
Oct 2525.64%
Oct 2524.09%
Sep 2524.22%
Sep 2522%
Sep 2520.86%
Sep 2517.82%
Aug 2517.9%
Aug 2514.29%
Aug 2515.16%
Aug 2515.6%
Aug 2515.98%
Jul 2514.41%
Price to Sales
2468med 3.75Aug 25Oct 25Jan 26Mar 26May 26Jul 26Sep 26
ARX Price to Sales by year
PeriodPrice to Sales
Sep 264.2
Sep 264.21
Aug 264.18
Aug 264.15
Aug 264.15
Aug 263.12
Jul 262.97
Jul 263.56
Jul 263.38
Jul 263.16
Jul 263.45
Jun 263.44
Jun 263.25
Jun 263.26
Jun 263.75
May 263.99
May 264.32
May 263.86
May 263.39
May 263.36
Apr 263.37
Apr 263.61
Apr 263.27
Apr 263.44
Mar 263.34
Mar 263.32
Mar 262.67
Mar 262.81
Feb 262.95
Feb 262.56
Feb 262.66
Feb 262.93
Jan 263.41
Jan 263.71
Jan 263.76
Jan 263.95
Jan 263.9
Dec 254.12
Dec 254.07
Dec 253.91
Dec 253.81
Nov 253.64
Nov 253.24
Nov 253.39
Nov 254
Oct 253.68
Oct 253.94
Oct 254.09
Oct 254.43
Oct 254.71
Sep 254.69
Sep 255.16
Sep 255.44
Sep 256.37
Aug 256.34
Aug 257.86
Aug 257.41
Aug 257.2
Aug 257.02
Jul 257.79
EV/EBITDA
010203040med 14.15Jul 25Aug 25Sep 25Sep 25Oct 25Nov 25
ARX EV/EBITDA by year
PeriodEV/EBITDA
Nov 256.15
Oct 254.17
Oct 255.82
Oct 256.69
Oct 258.79
Oct 2510.53
Sep 2510.38
Sep 2513.28
Sep 2515.01
Sep 2520.71
Aug 2520.52
Aug 2538.92
Aug 2535.43
Aug 2533.81
Aug 2532.45
Jul 2538.39
Price/Operating Cashflow
0255075100med 6.03Aug 25Oct 25Jan 26Mar 26May 26Jul 26Sep 26
ARX Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 2695.38
Sep 2695.58
Aug 2694.85
Aug 2694.18
Aug 2694.13
Aug 268.33
Jul 267.95
Jul 269.52
Jul 269.04
Jul 268.45
Jul 269.21
Jun 269.19
Jun 268.69
Jun 268.71
Jun 2610.03
May 2610.67
May 2611.54
May 2610.33
May 266.58
May 266.52
Apr 266.54
Apr 267.02
Apr 266.36
Apr 266.68
Mar 266.48
Mar 266.45
Mar 263.53
Mar 263.71
Feb 263.89
Feb 263.38
Feb 263.52
Feb 263.87
Jan 264.51
Jan 264.9
Jan 264.96
Jan 265.21
Jan 265.15
Dec 255.45
Dec 255.38
Dec 255.17
Dec 255.03
Nov 254.81
Nov 254.27
Nov 254.47
Nov 253.36
Oct 253.09
Oct 253.32
Oct 253.44
Oct 253.72
Oct 253.96
Sep 253.94
Sep 254.34
Sep 254.58
Sep 255.36
Aug 255.33
Aug 256.66
Aug 256.28
Aug 256.1
Aug 255.95
Jul 256.6
Price to Book
2.557.51012.5med 4.52Aug 25Oct 25Jan 26Mar 26May 26Jul 26Sep 26
ARX Price to Book by year
PeriodPrice to Book
Sep 265.87
Sep 265.88
Aug 265.84
Aug 265.8
Aug 265.79
Aug 263.84
Jul 263.66
Jul 264.39
Jul 264.17
Jul 263.9
Jul 264.25
Jun 264.24
Jun 264.01
Jun 264.02
Jun 264.62
May 264.92
May 265.32
May 264.76
May 264.03
May 264
Apr 264.01
Apr 264.3
Apr 263.9
Apr 264.1
Mar 263.97
Mar 263.95
Mar 263.14
Mar 263.29
Feb 263.45
Feb 263
Feb 263.12
Feb 263.43
Jan 264
Jan 264.35
Jan 264.4
Jan 264.63
Jan 264.57
Dec 254.83
Dec 254.78
Dec 254.59
Dec 254.46
Nov 254.27
Nov 253.79
Nov 253.97
Nov 255.77
Oct 255.3
Oct 255.69
Oct 255.89
Oct 256.39
Oct 256.8
Sep 256.76
Sep 257.45
Sep 257.85
Sep 259.19
Aug 259.15
Aug 2512.13
Aug 2511.43
Aug 2511.11
Aug 2510.84
Jul 2512.02
Accelerant Holdings
ARX
Stockpicker

Video analysis: ARX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ARX

Accelerant's Take-Private Deal Raises a Bigger Question for Insurance Stocks

marketbeat.com · 4 Sep 2026

Accelerant's Take-Private Deal Raises a Bigger Question for Insurance Stocks

Accelerant Holdings NYSE: ARX jumped into view for investors in mid-August after its shares surged 43% in a single day. This type of share price leap is often reserved for clinical-stage biotech firms announcing breakthrough results, for instance, not for an unglamorous firm connecting specialty insurance risk across a network of capital providers.

Accelerant (NYSE:ARX) Stock Price Passes Above Two Hundred Day Moving Average   – What’s Next?

defenseworld.net · 2 Sep 2026

Accelerant (NYSE:ARX) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next?

Accelerant Holdings (NYSE: ARX - Get Free Report)'s share price passed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $13.76 and traded as high as $19.78. Accelerant shares last traded at $19.77, with a volume of 1,488,977 shares changing hands. Analyst Upgrades and Downgrades A number

$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - CHMI, VREX, HHS and ARX

gurufocus.com · 23 Aug 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - CHMI, VREX, HHS and ARX

$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - CHMI, VREX, HHS and ARX PR Newswire

After Golden Cross, Accelerant Holdings (ARX)'s Technical Outlook is Bright

zacks.com · 21 Aug 2026

After Golden Cross, Accelerant Holdings (ARX)'s Technical Outlook is Bright

Accelerant Holdings (ARX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ARX's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?

gurufocus.com · 17 Aug 2026

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 17, 2026

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?

prnewswire.com · 17 Aug 2026

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

Why Is Accelerant Going Private Just One Year After Its IPO?

zacks.com · 17 Aug 2026

Why Is Accelerant Going Private Just One Year After Its IPO?

ARX is going private just over a year after its IPO, as Thoma Bravo's $4 billion deal capitalizes on stronger operating results.

Accelerant Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accelerant Holdings - ARX

gurufocus.com · 14 Aug 2026

Accelerant Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accelerant Holdings - ARX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (“KSF”) are investigating the propos

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.